Search
for
Did you mean Disease Activity?
Sort by
Research 30 of 1000+
- Clinical and Trichoscopic Patterns of Hair Loss in Systemic Lupus Erythematosus and its Correlation with Systemic Lupus Erythematosus Disease Activity Index (SLEDAI)
- GPX4 mRNA levels in the PMNs are negatively correlated with autoantibody production, disease activity and lupus alopecia in SLE
- 570 Examining cutaneous disease activity as an outcome measure for clinical trials in dermatomyositis
- Lichen Planus Activity and Damage Index (LiPADI)–Creation of the Questionnaire
- Can the Second to Fourth Digit Ratio (2D : 4D) Be a Marker to Determine Ankylosing Spondylitis Disease Activity?
- LP-159 Studying the disease activity and the degree of internal organ damage in systemic lupus erythematosus patients in the Kazakh population
- Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI
- Automated Machine Learning Analysis of Patients With Chronic Skin Disease Using a Medical Smartphone App: Retrospective Study
- Correlation of carotid intima media thickness and aortic stiffness index with androgenetic alopecia
- Effect of Alexandrite Laser Hair Removal on the Activity of Systemic Lupus Erythematosus
- Outcome Measures in Cutaneous Autoimmune Disease: Dermatomyositis and Lupus Erythematosus
- Administration of Nrf-2-Modified Hair-Follicle MSCs Ameliorates DSS-Induced Ulcerative Colitis in Rats
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Trichoscopic signs in systemic lupus erythematosus: a comparative study with 109 patients and 305 healthy controls
- Low‐Dose Oral Minoxidil in Lichen Planopilaris: Efficacy and Safety
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- 546 Gene expression signatures and ALADIN score correlates with response of alopecia areata patients to treatment with JAK inhibitors
- M2 Macrophage and Extracellular Matrix Genes Are Enriched in High‐Activity Lichen Planopilaris
- Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures
- Measures of Adult Systemic Lupus Erythematosus: Disease Activity and Damage
- 491 Efficacy of oral tofacitinib in the treatment of lichen planopilaris
- 151 Efficacy and adverse effects of oral Janus kinase inhibitor (JAKi) use in patients with lichen planopilaris: a retrospective case series and systematic review
- Increased risk of severe course of pemphigus in patients with pemphigus‐associated alopecia: a prospective observational study
- Baricitinib in the Treatment of Frontal Fibrosing Alopecia: Mid Trial Update
- Role of direct immunofluorescence on outer root sheath of hair follicle in monitoring disease activity of pemphigus vulgaris
- Health Benefits, Antioxidant Activity, and Sensory Attributes of Selected Cold-Pressed Oils
- Treatment of Obstructive Sleep Apnea Improves Cardiometabolic Function in Young Obese Women with Polycystic Ovary Syndrome
- POS0548 ACUTE AND SUBACUTE SKIN MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS ARE ASSOCIATED WITH AN EARLIER RESPONSE TO BELIMUMAB THAN THE CHRONIC PHENOTYPE: PRELIMINARY DATA FROM THE NEW NATION-WIDE COHORT OF BELIMUMAB IN REAL LIFE SETTING STUDY—NEW JOINT AND SKIN (BERLISS-NEJS)
- Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates